Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease

BACKGROUND: The thiopurine medications are well established in the treatment of inflammatory bowel disease (IBD). There is significant variation in levels of toxic and therapeutic metabolites. Current data from small or short-term studies support therapeutic drug monitoring (TDM) in assessing azathi...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Alex, Ooi, Soong-Yuan J., Lynch, Kate D., Parthasarathy, Nina, Bishara, Maria, Gounder, Michael, Grafton, Rachel, Leach, Peta, Bampton, Peter, Sechi, Alexandra, Ng, Watson, Connor, Susan, van Langenberg, Daniel, Mountifield, Réme, Andrews, Jane M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011286/
https://www.ncbi.nlm.nih.gov/pubmed/35687221
http://dx.doi.org/10.1007/s10620-022-07556-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011286/
https://www.ncbi.nlm.nih.gov/pubmed/35687221
http://dx.doi.org/10.1007/s10620-022-07556-y

Ejemplares similares